Skip to content

Author

S. Pollett

We have 2 of 124 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

RNAemia and Severe COVID-19: Candidate Treatment Targets Identified Through Transcriptomics.

Host gene expression changes associated with RNAemia, particularly involving OLAH, PCSK9, and ADAMTS2, had stronger statistical evidence of severe outcomes than RNAemia itself, and PCSK9 is an intervenable treatment target worth further study.

Sultanah Alharthi, N. Epsi, David A. Lindholm et al. · 0 citations
Open access Jul 2026

Durability and Breadth of Neutralizing Antibodies Against SARS-CoV-2 Variants Following XBB.1.5 Vaccination in a Multiply Exposed Cohort.

The observed waning of cross-neutralizing antibodies against emerging variants underscores the challenge of maintaining durable protection and supports the need for continued monitoring of antibody responses to guide evidence-based updates to COVID-19 vaccines.

Wei Wang, E. Goguet, Sabrina Lusvarghi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.